Cardiac metaiodobenzylguanidine activity can predict the long-term efficacy of angiotensin-converting enzyme inhibitors and/or beta-adrenoceptor blockers in patients with heart failure
Authors:
- 25 September 2004
- journal article
- clinical trial
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 32 (2) , 186-194
Abstract
Although the benefits of treatment with angiotensin-converting enzyme (ACE) inhibitors and beta-blockers are well known, no method has as yet been established to predict the efficacy of drug therapy. This study tested whether cardiac 123I-metaiodobenzylguanidine (MIBG) activity is of prognostic value and can predict the improvement in heart failure patients resulting from treatment with ACE inhibitors and/or beta-blockers.Keywords
This publication has 25 references indexed in Scilit:
- ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure)Circulation, 2001
- A Randomized Trial of the Angiotensin-Receptor Blocker Valsartan in Chronic Heart FailureNew England Journal of Medicine, 2001
- Regional Cardiac Sympathetic Nerve Dysfunction and the Diagnostic Efficacy of Metaiodobenzylguanidine Tomography in Stable Coronary Artery DiseaseThe American Journal of Cardiology, 1996
- Autonomic nervous system and sudden cardiac deathJACC, 1996
- Adverse consequences of high sympathetic nervous activity in the failing human heartJACC, 1995
- Regional cardiac sympathetic denervation in patients with ventricular tachycardia in the absence of coronary artery diseaseJACC, 1993
- Sympathetic Stimulation and ArrhythmiasNew England Journal of Medicine, 1991
- Regional cardiac adrenergic function using I-123 meta-iodobenzylguanidine tomographic imaging after acute myocardial infarctionThe American Journal of Cardiology, 1991
- Presynaptic modulation of efferent sympathetic and vagal neurotransmission in the canine heart by hypoxia, high K+, low pH, and adenosine. Possible relevance to ischemia-induced denervation.Circulation Research, 1990
- Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart FailureNew England Journal of Medicine, 1986